Skip to content
Abierto
Menu

Combined synopsis and solicitation

DiGeorge Syndrome (DGS) Patient Derived iPSCs

75N92024Q1031

National Institutes of Health, National Institutes of Health Nhlbi. All Other Professional, Scientific, and Technical Services.

View on SAM.govMarkdown

Awarded

New York Stem Cell Foundation Inc.

$26,250.00 obligated so far on USAspending

Description

As published on SAM.gov.

DiGeorge Syndrome (DGS) Patient Derived induced pluripotent stem cells (iPSCs)

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
New York Stem Cell Foundation Inc.
UEI
ZCKCL8KFL3B9
CAGE
5FLH1
Vendor location
New York, NY
Contract
75N92024P00257, purchase order
Obligated
$26,250.00
Actions
1 between August 5, 2024 and August 5, 2024
Competition
Competed Under SAP, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Digeorge Syndrome (Dgs) Patient Derived Induced Pluripotent Stem Cells (Ipscs)
Match
solicitation number 75N92024Q1031 equals the FPDS solicitation identifier; same awarding office 75N920 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. July 12, 2024

    Combined synopsis and solicitation

    Due July 19, 2024 at 4:00 PM EDT. SAM.gov, notice 49881e7cf9f5416bb53e8619da9eb458

Points of contact

Also open from this buyer